USPTO 2015–2025 USPTO PatentsView US Corporation

Agenus Inc.

USPTO PatentsView assignee record - 51 granted patents across 8 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

RSS updates for this company

The verdict

According to USPTO PatentsView, Agenus ranks #6,500 of 49,997 tracked US assignees by granted-patent volume, with 51 patents across 8 technology areas.

#6,500
of 49,997 US assignees by volume
Top 26%
by Innovation Score (44.2/100)
29.4
avg claims per patent
+280%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6500 · US Corporation #6,500 · 51 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 51 grants
  • UPPER-Q #6,500/49,997
  • PHOTO-FINISH Adama Makhteshim
  • CPC-NARROW C07K · 8 areas
  • INNOV-PAR 44.2/100
  • CLAIMS-DENSE 29.4 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +280% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Adama Makhteshim Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Agenus’s 44.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Agenus

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Agenus's Innovation Score is 44.2/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Agenus?

Each dot is one of Agenus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Agenus’s own 29.4 claims/patent is ABOVE the 18.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Agenus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 50.951.051.05151.051.051.1 010203040 Granted patents (volume) Avg claims / patent Adama Makhteshim Ltd. - 51, 17.96Adama MakhteshimAlphatheta Corporation - 51, 4.08AlphathetaAmvac Chemical Corporation - 51, 13.53Amvac ChemicalAST & Science, LLC - 51, 18.92AST & ScienceAnalytics For Life Inc. - 51, 19.78Analytics For LifeBauer Maschinen GmbH - 51, 12.06Bauer MaschinenBarracuda Networks, Inc. - 51, 22.37Barracuda NetworksBuilt Robotics Inc. - 51, 21.51Built RoboticsAgenus Inc. - 51, 29.37Agenus
Agenus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Agenus's grants concentrate

Agenus Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2020 (9 grants) versus a trough of 2 in 2017. By volume, Agenus sits between Adama Makhteshim Ltd. and Built Robotics Inc..

Agenus's three-year grant acceleration

From 2019–2021 to 2022–2024, Agenus Inc. moved from 24 to 20 grants (0.83x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Agenus's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Agenus holds 51 patents at rank #6,503, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Agenus

By rank, the assignees closest to #6,503 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Agenus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Agenus, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Agenus ranks #171 of 3,615 assignees by patent count in that subclass.

Agenus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 201720182019202020212022202320242025 3
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Agenus Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 2 3.9%
2018 2 3.9%
2019 6 11.8%
2020 9 17.6%
2021 9 17.6%
2022 9 17.6%
2023 5 9.8%
2024 6 11.8%
2025partial year 3 5.9%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Agenus Inc.'s patent record in context - here's where to go next.

  • Agenus Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
  • Ranked #6,500 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Agenus Inc. against Adama Makhteshim Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 44.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.